Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
|
|
Cerevel Therapeutics Holdings, Inc. (CERE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Renaud Ronald C JR (President & CEO) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Bought 83,857 shares
@ $23.9552, valued at
$2M
|
|
| 08/07/2023 |
4
| Burgess Paul D. (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Bought 21,880 shares
@ $22.9339, valued at
$501.8k
|
|
| 07/13/2023 |
4
| COLES N ANTHONY (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 50,000 shares
@ $30.0268, valued at
$1.5M
Exercised 50,000 options to buy
@ $3.5, valued at
$175k
|
|
| 07/06/2023 |
4
| Burgess Paul D. (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 95,931 options to buy
@ $31.45, valued at
$3M
Granted 23,847 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| BAIN CAPITAL INVESTORS LLC (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Disposed of 432,627 shares
@ $0 |
|
| 06/09/2023 |
4
| Gordon Christopher R (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Disposed of 432,627 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/09/2023 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Disposed of 432,627 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/09/2023 |
4
| Sulzberger Gabrielle (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/09/2023 |
4
| Giordano Douglas E. (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/09/2023 |
4
| Mckernan Ruth (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/09/2023 |
4
| PATRICK DEVAL L (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/09/2023 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 06/09/2023 |
4
| DEKKERS MARIJN E (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 3,282 shares
@ $0
Granted 13,780 options to buy
@ $32.6, valued at
$449.2k
|
|
| 05/08/2023 |
4
| COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 37,568 shares
@ $31.3636, valued at
$1.2M
Sold 12,132 shares
@ $31.7579, valued at
$385.3k
Sold 300 shares
@ $32.93, valued at
$9.9k
Exercised 50,000 options to buy
@ $3.5, valued at
$175k
|
|
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2023 |
4
| COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 47,000 shares
@ $27.1144, valued at
$1.3M
Sold 3,000 shares
@ $27.19, valued at
$81.6k
Exercised 47,000 options to buy
@ $3.5, valued at
$164.5k
Exercised 3,000 options to buy
@ $3.5, valued at
$10.5k
|
|
| 02/08/2023 |
4
| Renger John (Chief Scientific Officer) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 79,022 options to buy
@ $34.41, valued at
$2.7M
Granted 20,081 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Tregoning Kathleen (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 54,320 options to buy
@ $34.41, valued at
$1.9M
Granted 13,804 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Ceesay Abraham (President) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 114,445 options to buy
@ $34.41, valued at
$3.9M
Granted 29,083 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Akamine Scott (Chief Legal Officer) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 54,292 options to buy
@ $34.41, valued at
$1.9M
Granted 13,796 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 42,058 shares
@ $33.0437, valued at
$1.4M
Sold 7,942 shares
@ $33.5745, valued at
$266.6k
Granted 243,042 options to buy
@ $34.41, valued at
$8.4M
Granted 61,762 restricted stock units
@ $0
Exercised 50,000 options to buy
@ $3.5, valued at
$175k
|
|
| 02/08/2023 |
4
| Bodenrader Mark (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 20,012 options to buy
@ $34.41, valued at
$688.6k
Granted 5,085 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Sanchez Ramiro (Chief Medical Officer) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 97,691 options to buy
@ $34.41, valued at
$3.4M
Granted 24,825 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| DiPietro Kenneth (Chief Human Resources Officer) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 54,749 options to buy
@ $34.41, valued at
$1.9M
Granted 13,913 restricted stock units
@ $0 |
|
| 01/06/2023 |
4
| COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 49,500 shares
@ $29.9294, valued at
$1.5M
Sold 500 shares
@ $30.732, valued at
$15.4k
Exercised 50,000 options to buy
@ $3.5, valued at
$175k
|
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2022 |
4
| PATRICK DEVAL L (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 47,705 shares
@ $30.7813, valued at
$1.5M
Exercised 47,705 options to buy
@ $12.62, valued at
$602k
|
|
| 09/12/2022 |
4
| Ceesay Abraham (President) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 19,210 shares
@ $32.5, valued at
$624.3k
Exercised 19,210 options to buy
@ $13.17, valued at
$253k
|
|
| 08/24/2022 |
4
| Ceesay Abraham (President) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Sold 9,605 shares
@ $32.5, valued at
$312.2k
Exercised 9,605 options to buy
@ $13.17, valued at
$126.5k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|